Biological Chemistry Volume 374 Issue De Gruyterwww.degruyter.com › journal › key › bchm › html
www.degruyter.com
Ralph MOCIKAT, Josef MYSLIWIETZ, Peter LANG, Stefan THIERFELDER. Page range: Cite this. Download PDF. Unable to retrieve citations for this ...
CiteSeerX — Journal of Translational Medicine BioMed Central
citeseerx.ist.psu.edu
BibTeX @MISC{Adam07journalof, author = {Christian Adam and Josef Mysliwietz and Ralph Mocikat}, title = {Journal of Translational Medicine BioMed Central}, year ...
rationale for a new approach of tumor immunotherapy - PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Apr 30, · Authors. Nina Eissler , Josef Mysliwietz, Nina Deppisch, Peter Ruf, Horst Lindhofer, Ralph Mocikat. Affiliation.
Potential of the Trifunctional Bispecific Antibody Surek Depends on ...molmed.biomedcentral.com › articles › molmed
molmed.biomedcentral.com
Mar 28, · Josef Mysliwietz,; Nina Deppisch,; Peter Ruf,; […] Horst Lindhofer &; Ralph Mocikat ...
Potential of the Trifunctional Bispecific Antibody Surek NCBI
www.ncbi.nlm.nih.gov
... Depends on Dendritic Cells: Rationale for a New Approach of Tumor Immunotherapy. Nina Eissler, Josef Mysliwietz, [...], and Ralph Mocikat.
Specific targeting of whole lymphoma cells to dendritic cells ex vivo...
translational-medicine.biomedcentral.com
Research Specific targeting of whole lymphoma cells to dendritic cells ex vivo ... Christian Adam, Josef Mysliwietz and Ralph Mocikat * *
Journal of Translational Medicine - oalibwww.oalib.com › journal
www.oalib.com
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine · Christian Adam, Josef Mysliwietz, Ralph Mocikat ...
Journal of Translational Medicine BioMed Central - CORE
core.ac.uk
... Josef Mysliwietz and Ralph Mocikat. Abstract. Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine ...
Specific targeting of whole lymphoma cells to dendritic cells ex vivo...
core.ac.uk
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine. By Christian Adam, Josef Mysliwietz and Ralph Mocikat ...
Oalib search
www.oalib.com
Christian Adam, Josef Mysliwietz, Ralph Mocikat Journal of Translational Medicine , 2007, DOI: Abstract: We ...
All web results to the name "Josef Mysliwietz"
Shift from Systemic to Site-Specific Memory by Tumor-Targeted IL-2www.jimmunol.org › content › tab-article-info
www.jimmunol.org
Nina Eissler, Josef Mysliwietz, Nina Deppisch, Peter Ruf, Horst Lindhofer, Ralph Mocikat. Molecular Medicine
Trifunctional bispecific antibodies induce tumor-specific T cells and ...www.sigmaaldrich.com › tech-docs › paper
www.sigmaaldrich.com
Jun 30, · Nina Eissler, Peter Ruf, Josef Mysliwietz, Horst Lindhofer, Ralph Mocikat. PMID 要旨. A major goal of tumor immunotherapy is the ...
Antigen Binding and Effector Functions of a Chimeric Antibody with a...
www.degruyter.com
Ralph MOCIKAT, Josef MYSLIWIETZ, Peter LANG and Stefan THIERFELDER. GSF-Institut f r Immunologie M nchen. (Received 7 April 725 May 1993).
EBSCOhost | | Specific targeting of whole lymphoma cells to...
web.s.ebscohost.com
Christian Adam, Josef Mysliwietz and Ralph Mocikat*. Address: GSF-Institut für Molekulare ImmunologieMünchen ...
Potential of the trifunctional bispecific antibody surek depends on...
read.qxmd.com
... dendritic cells: rationale for a new approach of tumor immunotherapy. Nina Eissler, Josef Mysliwietz, Nina Deppisch, Peter Ruf, Horst Lindhofer, Ralph Mocikat.
Related search requests for Josef Mysliwietz
| Stefan Thierfelder Peter Camaj Horst Lindhofer | Bettina Schwarz Anja Torsvik Heike Immervoll | Christian Adam Albrecht Bergner Anja Kriegeskorte |
People Forename "Josef" (10388) Name "Mysliwietz" (3) |
sorted by relevance / date